Delivery Order SPE2DB22D1002-SPE2DB24FLFR5

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,653.24 firm-fixed-price delivery order is for the supply of 24,000 unit capsules of the pharmaceutical product Creon DR. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with numerous Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,801.09 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,515.15 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the drug CREON DR. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the provision of 36,000 unit capsules of the drug CREON DR. The $6,436.98 firm fixed-price delivery order has an ultimate completion date of January 17, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, worth $1,386.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award is a delivery order for 6,000 unit capsules of the pharmaceutical product CREON DR. As a major supplier of pharmaceutical and medical products to the U.S. government, Amerisourcebergen has been awarded numerous federal contracts, including a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,353.12 firm fixed price delivery order is for the supply of 36,000 units of CREON DR 100S capsules. The contract has a completion date of December 22, 2023 and was awarded on December 21, 2023. There was no set-aside designation used for this contract....
This federal contract award, valued at $2,946.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of a 100-count capsule product called CREON DR. This is a Firm Fixed Price Delivery Order contract with a completion date of March 14, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DX15D3018|SPE2DX24F0BGJ, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $13,335.85 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The contract has an ultimate completion date of September 19, 2024 and does not utilize any set-aside designation. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,521.00 Firm Fixed Price Delivery Order is for the supply of 36,000 unit capsules of a pharmaceutical product called "CREON DR 36,000 UNIT CAPSULE 100S". The award has an ultimate completion date of September 23, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,128.12 firm fixed price contract is for the supply of 36,000 unit capsules of the drug "CREON DR". The delivery order was issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FLFR5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,091.71 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The contract has a period of performance through July 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation for delivering a comprehensive range of medical commodities. This contract award is not designated as a set-aside.

Generated 10/29/24, 9:10 AM